European Association of Urology
Guidelines
Education & Events
Join our events Join our events
On-demand education Learn at your own pace
Scholarships Enrich your capabilities
Exchange Programmes Urology beyond Europe
Education Educational Platforms Talent Incubator Programme Accreditation
Science & Publications
Publications Our publications
Research & Science Passionate about research?
About
Who we are Our mission and history
Our Board and Offices How we work
Join the EAU Find out about membership
Vacancies Contact

First joint EAU-SIU session focusses on urothelial carcinoma

Fri, 11 Apr 2014

The first joint session of the European Association of Urology (EAU) and the Société Internationale d’Urologie (SIU) discussed risk stratification, conservative management and surgical approaches to urothelial carcinomas, with lively discussion and enthusiastic participation from the audience.

“Upper urinary tract carcinomas, and particularly their risk stratification, are a very new topic”, Prof. Morgan Roupret (FR) emphasized during his talk on risk stratification in upper tract urothelial carcinomas (UTUCs). While there is a low incidence, particularly when compared with bladder urothelial cancers, the array of treatment options is still large. Focussing on specific elective cases, when the patient has two functioning kidneys, Roupret stressed the benefits of conservative management, adding that the patient “must follow a stringent approach, and very precisely”.

Prof. Chris Heyns (ZA) and Prof. Joachim Thüroff (DE), co-chairs of this session, then opened the floor for Prof. Jean de la Rosette (NL) to expand upon the subject of conservative management of UTUCs. He presented research on new tools, such as optical coherence tomography (OCT) and endoluminal ultrasound (ELUS). He added that these new methods, particularly a combination of OCT and ELUS, would provide more and better information about the patient’s condition. With this knowledge, it will be easier to select cases and subsequent options for treatment. Some of these approaches, based on the field of cardiology, are still very new. While they are promising, “we cannot guarantee they can be offered to all patients. Treatment is expensive, although it can be a worthwhile investment”.

Novel diagnostics and treatment approaches to high grade upper tract urothelial carcinoma were discussed next by Prof. Arnulf Stenzl (DE). His talk touched upon four main topics: the open or laparoscopic debate, RNU or parenchymal sparing surgery and segmental resection, bladder cuff management, and lymphadenectomy. He underlined the factors that increase the risk of metastases, in particular the location of the tumour. He closed his participation with the reflection that “upper urinary tract carcinoma is a thorny issue, and we should not overestimate what we know”.

The role of lymph node dissection, and robotic surgery in urothelial carcinomas were also debated in this session. The morning closed with notes by Prof. Thüroff on patient selection and technical tips in the case of continent urinary diversion. The topic of UTUC still has room for research, and more details are available in the updated EAU Guidelines on Urothelial Carcinomas of the Upper Urinary Tract.

Share this article

About EAU
  • Who we are
  • How we work
  • Become a member
Services
  • MyEAU
  • Congress registrations
  • Abstract submission
Media
  • EAU News
  • EAU Newsletter
  • EAU Press Releases
Contact
  • EAU Central Office
    PO Box 30016
    NL-6803 AA ARNHEM
    The Netherlands

  • Contact us
About EAU
Who we areHow we workBecome a member
Services
MyEAUCongress registrationsAbstract submission
Media
EAU NewsEAU NewsletterEAU Press Releases
Contact

EAU Central Office
PO Box 30016
NL-6803 AA ARNHEM
The Netherlands

Contact us
European Association of Urology
Privacy PolicyDisclaimer